Ketamine as an Adjuvant Therapy for Acute Vaso Occlusive Crisis in Pediatric Patients With Sickle Cell Disease
Clinical trial NCT02801292 · UNKNOWN
Trial details
- NCT number
- NCT02801292
- Sponsor
- Augusta University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2018-07-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.